Current news on doabetes who 2016
I think you meant "diabetes"!
Here are some notable news stories related to diabetes from 2016:
- New guidelines for type 2 diabetes diagnosis: In February 2016, the American Diabetes Association (ADA) released new guidelines for diagnosing type 2 diabetes, which emphasized the importance of considering individual risk factors and using a combination of tests to diagnose the condition.
- SGLT-2 inhibitors approved for type 2 diabetes: In June 2016, the FDA approved the SGLT-2 inhibitor canagliflozin (Invokana) for the treatment of type 2 diabetes. This class of medications has been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes.
- Artificial pancreas system approved: In July 2016, the FDA approved the first artificial pancreas system, the MiniMed 670G system, which is designed to automatically monitor blood glucose levels and deliver insulin as needed.
- New oral medication for type 2 diabetes: In August 2016, the FDA approved the oral medication semaglutide (Ozempic) for the treatment of type 2 diabetes. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been shown to improve glycemic control and reduce the risk of cardiovascular events.
- Diabetes and Alzheimer's disease link: In September 2016, a study published in the journal Neurology found that people with type 2 diabetes were more likely to develop Alzheimer's disease than those without diabetes. This study highlighted the importance of managing blood sugar levels to reduce the risk of cognitive decline.
- Global diabetes prevalence on the rise: In November 2016, the International Diabetes Federation (IDF) released a report highlighting the growing prevalence of diabetes worldwide. The report estimated that 415 million people worldwide had diabetes in 2015, and that this number is expected to rise to 642 million by 2040.
These are just a few examples of the many news stories related to diabetes that were published in 2016.